Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -24.82 % |
3 Month Return | + 17.24 % |
1 Year Return | + 36 % |
Market Stats | |
Previous Close | ₹210.75 |
Open | ₹214.00 |
Volume | 1.20L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,398.64Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹1,398.64 Cr |
P/B Ratio | 3.95 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 12.97 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,398.64 Cr | 352.35% | 0.52 | NA | NA | |
NA | ₹25.78 Cr | 98.92% | 0.50 | NA | NA | |
NA | ₹12.45 Cr | 61.71% | 0.50 | NA | NA | |
NA | ₹167.89 Cr | 40.7% | 0.72 | -₹10 Cr | ₹368 Cr | |
HOLD | ₹19,695.63 Cr | 14.34% | 0.55 | ₹615 Cr | ₹6,228 Cr |
Organisation | Jagsonpal Pharmaceuticals Ltd |
Headquarters | Gurgaon |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Announces Stock Split - 04 Jan, 2025
Jagsonpal Pharmaceuticals Announces Stock Split Record Date - 18 Dec, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 29.62% to 30.08% in Dec 2024 quarter
Price Dip
In the last 7 days, JAGSNPHARM stock has moved down by -22.9%
Promoter Holding Down
Promoters have decreased holdings from 67.97% to 67.81% in Dec 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 2.30% to 2.10% in Dec 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 0.11% to 0.00% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 67.81% | ||
Foreign Institutions | 2.1% | ||
Mutual Funds | 0% | ||
Retail Investors | 30.08% | 1.57 | |
Others | 0% |
Jagsonpal Pharmaceuticals Ltd’s net profit jumped 53.41% since last year same period to ₹11.46Cr in the Q2 2024-2025. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated 115.01% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Jagsonpal Pharmaceuticals Ltd has declared dividend of ₹5 - translating a dividend yield of 4.49%.
Read More about DividendsBearish
Neutral
Bullish
Jagsonpal Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) share price today is ₹222.95
Jagsonpal Pharmaceuticals Ltd is listed on NSE
Jagsonpal Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) is 1.20L.
Today’s market capitalisation of Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) is ₹1398.64Cr.
Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM | Price |
---|---|
52 Week High | ₹328.04 |
52 Week Low | ₹109.44 |
Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) share price is ₹222.95. It is down -32.04% from its 52 Week High price of ₹328.04
Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) share price is ₹222.95. It is up 103.72% from its 52 Week Low price of ₹109.44
Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM | Returns |
---|---|
1 Day Returns | 12.2% |
1 Month Returns | -24.82% |
3 Month Returns | 17.24% |
1 Year Returns | 36% |